AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grant, W. B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grant, W. B
Agricola
Right arrow Articles by Grant, W. B
American Journal of Clinical Nutrition, Vol. 70, No. 2, 301A-302, August 1999
© 1999 American Society for Clinical Nutrition


Letters to the Editor

Lactose maldigestion and calcium from dairy products

William B Grant

12 Sir Francis Wyatt Place Newport News, VA 23606-3660 E-mail: wbgrant{at}norfolk.infi.net

Dear Sir:

The recent publication of a paper in this Journal suggesting that lactose maldigestion should not be considered an impediment to consuming dairy products to obtain dietary calcium (1), which was sponsored by the National Dairy Council, may mislead the readers. First, dairy products may not be a good source of calcium for reasons other than lactose intolerance. A recent report from the Nurses' Health Study, which included 121701 women aged 30–55 y at enrollment in 1976, concluded that the cohort study data do not support the hypothesis that a high consumption of milk or other food sources of calcium by adult women protects against hip or forearm fractures (2).

To examine the link between milk and osteoporosis further, an ecologic approach was used to study hip fracture incidence rates for the white and total populations from 9 countries (3). The data for Finnish women were omitted because they were both an outlier with respect to women from other countries and inconsistent with rates of hip fracture for the Finnish men. As shown in Table 1, dietary milk and its components, especially milk protein, have a much higher statistical association with hip fracture incidence than do other likely factors such as fat, protein, and sweeteners (4). When linear regressions were run for milk protein, the r value for women was 0.800 (P = 0.005) and for men was 0.593 (P = 0.054). What the statistical results show is that living in countries with a high dairy consumption is a risk factor for osteoporosis. They do not necessarily imply that consumption of dairy products causes osteoporosis; however, they do suggest that further investigations be conducted to determine why the associations are so high.

In addition, the annual hip-fracture rate of black females in California was 43% that of white females (219 compared with 559 cases/100000 persons) (3), whereas the hip-fracture rate of black females in Washington, DC, was 51% that of white females (118.8 compared with 231.8 cases/100000 persons) (5, 6). African Americans are generally lactose intolerant and have lower milk consumption rates than do white Americans. Perhaps their diet, genetic makeup, or both lead to strong bones and therefore dairy products or large amounts of dietary calcium are not as important as they are for whites.

Other common chronic diseases are now linked to calcium and milk consumption. Lactose from unfermented dairy products such as milk and yogurt has the highest association with ischemic heart disease of any dietary macronutrient for men of all ages and postmenopausal women (79). A possible mechanism is the metabolism of lactose into triacylglycerol and its incorporation into VLDL cholesterol. In addition, milk and calcium intakes have been found in cohort studies in 5 countries to be the highest risk factors for prostate cancer (10). The proposed mechanism is a reduction in circulating vitamin D by calcium because vitamin D is involved in the incorporation of calcium into bone (10). Vitamin D has been shown to kill prostate cancer cells in vitro (11).

Thus, there are many good reasons not to consume dairy products. Those concerned about osteoporosis, which has a complex etiology, should review the report by Brown (5), which delves far beyond the relation between osteoporosis and calcium intakes into such other factors as the dietary acid-alkaline balance, trace minerals, exercise, and exposure to sunlight.

REFERENCES

  1. Suarez FL, Adshead J, Furne JK, Levitt MD. Lactose maldigestion is not an impediment to the intake of 1500 mg calcium daily as dairy products. Am J Clin Nutr 1998;68:1118–22.[Abstract]
  2. Feskanich D, Willett WC, Stampfer MJ, Colditz GA. Milk, dietary calcium, and bone fractures in women: a 12-year prospective study. Am J Public Health 1997;87:992–7.[Abstract/Free Full Text]
  3. Maggi S, Kelsey JL, Litvak J, Hayes SP. Incidence of hip fractures in the elderly. A cross-national analysis. Osteoporos Int 1991;1:232–41.[Medline]
  4. Food and Agriculture Organization. Food balance sheets. Rome: FAO, 1991.
  5. Brown SE. Better bones, better body. New Canaan, CT: Keats Publishing, Inc, 1996.
  6. Melton L. Epidemiology of fractures, osteoporosis etiology, diagnosis and management. In: Riggs B, Melton L, eds. New York: Raven Press, 1988:133–54.
  7. Artaud-Wild SM, Connor SL, Sexton G, et al. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland: a paradox. Circulation 1993;88:2771–9.[Abstract/Free Full Text]
  8. Segall JJ. Epidemiological evidence for the link between dietary lactose and atherosclerosis. In: Colaco C, ed. The glycation hypothesis of atherosclerosis. Austin, TX: Landes Bioscience, 1997:185–209.
  9. Grant WB. Milk and other dietary influences on coronary heart disease. Altern Med Rev 1998;3:281–94.[Medline]
  10. Grant WB. An ecologic study of dietary links to prostate cancer. Altern Med Rev 1999;4:162–9.[Medline]
  11. Schwartz GG, Hill CC, Oeler TA, Becich MJ, Bahnson RR. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo. Urology 1995;46:365–9.[Medline]




This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grant, W. B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grant, W. B
Agricola
Right arrow Articles by Grant, W. B


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS